Our science

Abstracts

ReAlta Life Sciences Has A Strong Series Of Publications In Peer-Reviewed Scientific Journals

Apr 25, 2025

Pharmacokinetics of RLS-0071, a Novel Anti-Inflammatory Peptide, in Newborns...

Background: Hypoxic ischemic encephalopathy (HIE) is a common cause of mortality and life-long disabilities. RLS-0071 is a novel anti-inflammatory peptide...

Read More
Apr 25, 2025

Early Granulocyte Inflammatory Biomarkers in Newborn Babies with Moderate...

Background: Hypoxic ischemic encephalopathy (HIE) occurs when an infant’s brain is deprived of oxygenated blood flow during the perinatal period....

Read More
Dec 08, 2024

Exploring a Novel Anti-Inflammatory Peptide As a Potential Treatment...

Introduction: Allogeneic hematopoietic cell transplantation (allo-HCT) is indicated for the treatment of many hematological diseases, including leukemia. The goal is...

Read More
Jun 02, 2023

RLS-0071, A Novel Dual-targeting Anti-inflammatory Agent, Demonstrates Proof of...

RATIONALE: Neutrophils play an important role in several lung diseases such as acute lung injury, adult respiratory distress syndrome (ARDS),...

Read More
Feb 09, 2022

The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides,...

Abstract The EPICC peptides are a family of peptides that have been developed from the sequence of the capsid protein...

Read More
Oct 28, 2021

Peptide inhibition of acute lung injury in a novel...

Acute lung injury (ALI) often causes severe trauma that may progress to significant morbidity and mortality. ALI results from a...

Read More
Oct 07, 2021

Classical complement pathway inhibition reduces brain damage in a...

Abstract Perinatal hypoxic ischemic encephalopathy (HIE) remains a major contributor of infant death and long-term disability worldwide. The role played...

Read More
Feb 06, 2021

Delayed Hemolytic Transfusion Reaction in a Patient With Sickle...

A 14-year-old female patient with sickle cell disease developed a severe delayed hemolytic transfusion reaction (DHTR) leading to multiple transfusions...

Read More
Aug 31, 2020

A complement-mediated rat xenotransfusion model of platelet refractoriness

Background: Platelet refractoriness remains a challenging clinical dilemma although significant advancements have been made in identifying human leukocyte antigen (HLA)...

Read More